The Polynovo Ltd (ASX: PNV) share price is taking off on Tuesday despite the broader market’s downturn.
At the time of writing, the Polynovo share price is $1.09, 17.2% higher than its previous close. Additionally, the medical device company’s chair has snapped up another parcel of Polynovo shares.
For context, the All Ordinaries Index (ASX: XAO) and the S&P/ASX 200 Index (ASX: XJO) are both down around 1.3% right now. That marks a slight recovery after the indexes both hit a three-month low this morning.
Let’s take a closer look at what might be going on with the Polynovo share price today.
What’s going on with Polynovo today?
The Polynovo share price is surging 17% today amid more news of insider buying.
An entity owned by the company’s chair David Williams splashed out yesterday, snapping up $227,500 worth of Polynovo stock on the market.
The purchase saw the entity taking home 250,000 shares at a cost of 91 cents apiece. Thus, they’re already bringing a 19.8% return on investment.
That – and the 1.5 million shares Williams purchased last week – has brought his holding in the company to 20.65 million shares.
Additionally, another two of the company’s directors reported buying into its stock last week, each snapping up parcels of 100,000 shares.
That might suggest insiders believe the Polynovo share price recently bottomed out.
Today’s gains see the medical device company’s stock surpassing $1 for the first time in nearly two months. That’s a win for investors, but it might be disappointing news for those shorting the stock.
The most recent data available shows 10% of Polynovo shares are in the hands of short-sellers, making it the fifth most shorted stock on the ASX, according to The Motley Fool Australia’s latest weekly short-selling breakdown.
Polynovo share price snapshot
Should you invest $1,000 in Polynovo right now?
Before you consider Polynovo, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
- Why EOS, Pendal, PolyNovo and Xero shares are charging higher
- Why BrainChip, PolyNovo, TPG, and Westpac shares are pushing higher
- Down 40% in 2022, this ASX 200 share is climbing amid insider buying action
- These are the 10 most shorted ASX shares
- Why BrainChip, Coles, Fisher & Paykel Healthcare, and PolyNovo shares are rising
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/u9ktPRS